« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 3
, Pages 273-280
, March 2009
Elevated Body Mass Index and Use of Coronary Revascularization after Cardiac Catheterization
References
- . Bias, discrimination, and obesity. Obesity Res. 2001;9:788–805
- . Implicit anti-fat bias among health professionals (Is anyone immune?). Intern J Obesity. 2001;25:1525–1531
- . Access and use of medical care among obese persons. Obesity Res. 2000;8:403–406
- . Overweight women delay medical care. Arch Fam Med. 1994;3:888–892
- . Body weight and health care among women in the general population. Arch Fam Med. 1998;7:381–384
- . Utilization of health care resources by obese Canadians. CMAJ. 1999;160:1457–1462
- LePetit C, Berthelot J-M. Obesity: a growing issue. Statistics Canada Catalogue no. 82-618-MWE2005003.
- . Prevalence of class I, II and III obesity in Canada. CMAJ. 2006;174:156–157
- Trends and correlates of class 3 obesity in the United States from 1990-2000. JAMA. 2002;288:1758–1761
- . Increases in clinically severe obesity in the United States, 1976-2000. Arch Intern Med. 2003;163:2146–2148
- Obesity and long-term clinical and economic outcomes in coronary artery disease patients. Obesity Res. 2002;10:83–91
- Variations in coronary procedure utilization depending on body mass index. Arch Intern Med. 2004;165:1381–1387
- Excess body weight, clinical profile, management practices, and hospital prognosis in men and women after acute myocardial infarction. Am Heart J. 2006;151:1297–1304
- . Overview of the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease. Can J Cardiol. 2000;16:1225–1230
- . Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CMAJ. 2005;172:995–998
- Kaplan-Meier methods yield misleading results in competing risk scenarios. J Clin Epidemiol. 2006;59:1110–1114
- Sex differences in access to coronary revascularization after cardiac catheterization: Importance of detailed clinical data. Ann Intern Med. 2002;136:723–732
- Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 1996;111:1013–1025
- Time to first new myocardial infarction in patients with severe angina and three-vessel disease comparing medical and early surgical therapy: a CASS registry study of survival. J Thorac Cardiovasc Surg. 1988;95:382–389
- Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol. 2006;26:968–976
- Obesity and long-term clinical and economic outcomes in coronary artery disease patients. Obes Res. 2002;10:83–91
- Mortality and cardiac and vascular outcomes in extremely obese women. JAMA. 2006;296:79–86
- . Is obesity a risk factor for mortality in coronary artery bypass surgery?. Circulation. 2005;111:3359–3365
- . The impact of body mass index on short-and long-term outcomes in patients undergoing coronary revascularization (Insights from the bypass angioplasty revascularization investigation (BARI)). J Am Coll Cardiol. 2002;39:834–840
- The effect of obesity on mid-term survival following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2003;23:368–373
Funding: The Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease was initially funded with a grant from the W. Garfield Weston Foundation. The ongoing operation of this project has been made possible by operating grants from the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut, and the Canadian Institutes of Health Research, as well as support from the Canadian Cardiovascular Outcomes Research Team, a Canadian Institutes of Health Research-funded team grant initiative. The initiative also has received contributions from Alberta Health and Wellness, Merck Frosst Canada Inc, Monsanto Canada Inc-Searle, Eli Lilly Canada Inc, Guidant Corporation, Boston Scientific Ltd, Hoffmann-La Roche Ltd, and Johnson & Johnson Inc—Cordis. Dr King holds a Health Scholar Award from the Alberta Heritage Foundation for Medical Research. Dr Knudtson receives partial support from the Libin Trust Fund. Dr Ghali is supported by a Government of Canada Research Chair in Health Services Research and by a Senior Health Scholar Award from the Alberta Heritage Foundation for Medical Research.
Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this article.
Authorship: All authors had access to the data and played a role in writing this article.
PII: S0002-9343(08)00985-6
doi: 10.1016/j.amjmed.2008.09.036
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 122, Issue 3
, Pages 273-280
, March 2009

